Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP270 is a **human pseudogene** related to the RNA, 7SK small nuclear RNA (RN7SK), an abundant noncoding RNA that serves as a transcriptional regulator by controlling the activity of positive transcription elongation factor b (P-TEFb)[1][5][6]. Pseudogenes like RN7SKP270 arise from duplication or retrotransposition events, but lack the capacity for normal gene function due to accumulated mutations, absence of promoters, or inability to produce functional RNA/protein. There is no evidence that RN7SKP270 encodes a product with biological activity, nor that it participates in regulation, disease, or therapeutic response. Its sequence and structure are derived from RN7SK, but it is generally considered *genomically inert* except as a potential model for evolutionary studies[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 270 (RN7SKP270).